Lipidomics analysis of monocytes from patients with acute myocardial infarction reveals lactosylceramide as a new player in monocyte migration

Monocyte recruitment after vascular injury and their migration through the vessel wall represent crucial events in the initiation, progression, and destabilization of atherosclerotic plaque. Circulating monocytes are exposed to stimuli that alter their physiological state, and among them, lipids play a key role. Several studies investigated the mechanisms by which lipids affect monocyte functions promoting coronary atherosclerotic plaque initiation, but information on the relationship between lipid composition and function of monocyte is scant. We aimed at studying the migration of circulating monocytes isolated from patients with acute myocardial infarction (AMI) at hospital presentation and investigating its correlation with cellular lipid profile. The migration of monocytes was tested using both fetal bovine serum (FBS) and autologous serum as chemoattractant stimuli. Monocyte lipid profile was evaluated through an untargeted lipidomics approach, using a liquid chromatography/time‐of‐flight mass spectrometry platform. We observed that AMI patients' monocytes showed a significant increase in FBS and autologous serum‐mediated migration compared to controls. Moreover, a different monocyte lipidomic profile between the two study groups was detected. In particular, AMI patients' monocytes showed an altered composition in ceramides, with an increase in lactosylceramide and in phospholipids (ie, phosphatidylethanolamine and lisophosphatidylethanolamine). Of note, a positive correlation between lactosylceramide levels and monocyte migration was observed. Furthermore, the lactosylceramide synthase inhibition significantly reduced FBS‐induced monocyte migration. Our results highlight the influence of lactosylceramide on the monocyte migration capacity, pointing out a new possible mechanism of lipids in the onset of atherothrombosis and, hence, in AMI.

[1]  G. Preta,et al.  Lipids in the cell: organisation regulates function , 2018, Cellular and Molecular Life Sciences.

[2]  M. Netea,et al.  Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases , 2017, European heart journal.

[3]  L. Joosten,et al.  Monocyte and macrophage immunometabolism in atherosclerosis , 2017, Seminars in Immunopathology.

[4]  D. Vance,et al.  The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. , 2017, Biochimica et biophysica acta. Biomembranes.

[5]  H. Medbury,et al.  Monocyte inflammatory profile is specific for individuals and associated with altered blood lipid levels. , 2017, Atherosclerosis.

[6]  C. Ballantyne,et al.  Postprandial Monocyte Activation in Individuals With Metabolic Syndrome. , 2016, The Journal of clinical endocrinology and metabolism.

[7]  J. Borén,et al.  Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation. , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[8]  S. Parthasarathy,et al.  Differential lipid metabolism in monocytes and macrophages: influence of cholesterol loading[S] , 2016, Journal of Lipid Research.

[9]  L. Badimón,et al.  LDL accelerates monocyte to macrophage differentiation: Effects on adhesion and anoikis. , 2016, Atherosclerosis.

[10]  K. Woollard,et al.  Very-low and low-density lipoproteins induce neutral lipid accumulation and impair migration in monocyte subsets , 2016, Scientific Reports.

[11]  L. Becker,et al.  Phospholipid alterations in the brain and heart in a rat model of asphyxia-induced cardiac arrest and cardiopulmonary bypass resuscitation , 2015, Molecular and Cellular Biochemistry.

[12]  G. Maurer,et al.  Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a) , 2015, Journal of clinical lipidology.

[13]  Allyson L. Byrd,et al.  Bone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection. , 2015, Immunity.

[14]  G. Maurer,et al.  Association of Small Dense LDL Serum Levels and Circulating Monocyte Subsets in Stable Coronary Artery Disease , 2015, PloS one.

[15]  H. Daida,et al.  Possible Involvement of Minor Lysophospholipids in the Increase in Plasma Lysophosphatidic Acid in Acute Coronary Syndrome , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[16]  G. Maurer,et al.  Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease , 2014, Atherosclerosis.

[17]  T. Pavlunina,et al.  A Cytofluorometric Study of Membrane Rafts in Human Monocyte Subsets in Atherosclerosis , 2014, Acta naturae.

[18]  L. Joosten,et al.  Oxidized Low-Density Lipoprotein Induces Long-Term Proinflammatory Cytokine Production and Foam Cell Formation via Epigenetic Reprogramming of Monocytes , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[19]  D. Fliser,et al.  CD14 CD16 Monocytes Independently Predict Cardiovascular Events , 2012 .

[20]  N. V. Prokazova,et al.  Activation of ganglioside GM3 biosynthesis in human blood mononuclear cells in atherosclerosis , 2012, Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry.

[21]  R. Xavier,et al.  Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. , 2012, Cell host & microbe.

[22]  A. Didangelos,et al.  The -omics era: proteomics and lipidomics in vascular research. , 2012, Atherosclerosis.

[23]  K. Clément,et al.  CD14dimCD16+ and CD14+CD16+ Monocytes in Obesity and During Weight Loss: Relationships With Fat Mass and Subclinical Atherosclerosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[24]  D. Rader,et al.  Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression. , 2011, The Journal of clinical investigation.

[25]  R. Gower,et al.  CD11c/CD18 Expression Is Upregulated on Blood Monocytes During Hypertriglyceridemia and Enhances Adhesion to Vascular Cell Adhesion Molecule-1 , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Hiroto Tsujioka,et al.  Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris. , 2010, Atherosclerosis.

[27]  T. Huser,et al.  Fatty Acids from Very Low-Density Lipoprotein Lipolysis Products Induce Lipid Droplet Accumulation in Human Monocytes , 2010, The Journal of Immunology.

[28]  D. Fliser,et al.  Monocyte heterogeneity in obesity and subclinical atherosclerosis. , 2010, European heart journal.

[29]  F. Geissmann,et al.  Monocytes in atherosclerosis: subsets and functions , 2010, Nature Reviews Cardiology.

[30]  P. Lin,et al.  Lactosylceramide promotes cell migration and proliferation through activation of ERK1/2 in human aortic smooth muscle cells. , 2009, American journal of physiology. Heart and circulatory physiology.

[31]  M. Rajesh,et al.  Regulation of lactosylceramide synthase (glucosylceramide beta1-->4 galactosyltransferase); implication as a drug target. , 2008, Current drug targets.

[32]  S. Hakomori,et al.  Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. , 2008, Biochimica et biophysica acta.

[33]  R. Schneiter,et al.  Lipid signalling in disease , 2008, Nature Reviews Molecular Cell Biology.

[34]  Mi-Kyoung Kim,et al.  Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK‐OV3 human ovarian cancer cells: Involvement of pertussis toxin‐sensitive G‐protein coupled receptor , 2007, FEBS letters.

[35]  P. Libby,et al.  Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease , 2006, Proceedings of the National Academy of Sciences.

[36]  G. Schmitz,et al.  E‐LDL and Ox‐LDL differentially regulate ceramide and cholesterol raft microdomains in human Macrophages , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[37]  A. Pasqui,et al.  Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes , 2006, Clinical and Experimental Medicine.

[38]  P. Libby,et al.  Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells , 2006, Circulation.

[39]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[40]  M. Rajesh,et al.  Novel Role of Lactosylceramide in Vascular Endothelial Growth Factor–Mediated Angiogenesis in Human Endothelial Cells , 2005, Circulation research.

[41]  Heming Wei,et al.  Lactosylceramide recruits PKCα/ε and phospholipase A2 to stimulate PECAM-1 expression in human monocytes and adhesion to endothelial cells , 2004 .

[42]  G. Rothe,et al.  Enzymatically Degraded LDL Preferentially Binds to CD14high CD16+ Monocytes and Induces Foam Cell Formation Mediated Only in Part by the Class B Scavenger-Receptor CD36 , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[43]  A. Bhunia,et al.  Lactosylceramide Mediates Tumor Necrosis Factor-α-induced Intercellular Adhesion Molecule-1 (ICAM-1) Expression and the Adhesion of Neutrophil in Human Umbilical Vein Endothelial Cells* , 1998, The Journal of Biological Chemistry.

[44]  S. Chatterjee.  Sphingolipids in atherosclerosis and vascular biology. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[45]  G. Hutchins,et al.  Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues. , 1997, Glycobiology.

[46]  P. Kwiterovich,et al.  Uptake and metabolism of lactosylceramide on low density lipoproteins in cultured proximal tubular cells from normal and familial hypercholesterolemic homozygotes. , 1986, The Journal of biological chemistry.

[47]  R. Gower,et al.  CD 11 c / CD 18 Expression Is Upregulated on Blood Monocytes During Hypertriglyceridemia and Enhances Adhesion to Vascular Cell Adhesion Molecule-1 , 2010 .

[48]  S. Sonnino,et al.  Gangliosides as components of lipid membrane domains. , 2007, Glycobiology.

[49]  S. Blankenberg,et al.  CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. , 2004, Thrombosis and haemostasis.

[50]  Heming Wei,et al.  Lactosylceramide recruits PKCalpha/epsilon and phospholipase A2 to stimulate PECAM-1 expression in human monocytes and adhesion to endothelial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.